Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for T2DM, exert both metabolic and anti-inflammatory effects, which may offer therapeutic benefits for psoriatic disease, particularly in the early stages of PsA
GLP-1 Antidiabetic Medication NAION Vision Loss Study The recent study published in medical journal, JAMA Ophthalmology, examined vision loss or blindness in people who took GLP-1 antidiabetic medication
New or worsening reflux symptoms that don't respond to simple measures should be discussed, as GLP-1 medications are not recommended in severe gastrointestinal disease
Sweating is a classic warning sign of hypoglycaemia, often accompanied by trembling, palpitations, confusion, and hunger
Hoffmann-La Roche Ltd) is a Swiss company founded in 1896, now one of the worlds largest biotechnology and diagnostics firms ( [13] )